- Home
- ROIV vs FSLR Comparison
ROIV vs FSLR Comparison
Compare ROIV & FSLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ROIV | FSLR |
|---|---|---|
| Founded | 2014 | 1999 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.7B | 23.6B |
| IPO Year | 2021 | 2006 |
Fundamental Metrics
Financial Performance| Metric | ROIV | FSLR |
|---|---|---|
| Price | $29.34 | $233.85 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 27 |
| Target Price | $28.94 | ★ $236.42 |
| AVG Volume (30 Days) | ★ 4.4M | 2.4M |
| Earning Date | 05-28-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 18.22 |
| EPS | N/A | ★ 3.22 |
| Revenue | $29,053,000.00 | ★ $5,219,376,000.00 |
| Revenue This Year | N/A | $1.43 |
| Revenue Next Year | $744.61 | $16.77 |
| P/E Ratio | ★ N/A | $70.90 |
| Revenue Growth | N/A | ★ 24.09 |
| 52 Week Low | $10.58 | $135.50 |
| 52 Week High | $30.33 | $285.99 |
Technical Indicators
Market Signals| Indicator | ROIV | FSLR |
|---|---|---|
| Relative Strength Index (RSI) | 59.02 | 69.20 |
| Support Level | $27.00 | $216.37 |
| Resistance Level | $30.26 | $250.73 |
| Average True Range (ATR) | 0.87 | 10.39 |
| MACD | 0.09 | 3.75 |
| Stochastic Oscillator | 85.95 | 89.59 |
Price Performance
Historical ComparisonAbout ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About FSLR First Solar Inc.
First Solar designs and manufactures solar photovoltaic panels, modules, and systems for use in utility-scale development projects. The company's solar modules use cadmium telluride to convert sunlight into electricity. This is commonly called thin-film technology. First Solar is the world's largest thin-film solar module manufacturer. It has production lines in Vietnam, Malaysia, the United States, and India.